<s> Italian chemical giant Montedison S.p.A. , through its Montedison Acquisition N.V. indirect unit , began its $ 37-a-share tender offer for all the common shares outstanding of Erbamont N.V. , a maker of pharmaceuticals incorporated in the Netherlands . </s>
<s> The offer , advertised in today 's editions of The Wall Street Journal , is scheduled to expire at the end of November . </s>
<s> Montedison currently owns about 72 % of Erbamont 's common shares outstanding . </s>
<s> The offer is being launched pursuant to a previously announced agreement between the companies . </s>
